These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7037781)

  • 1. Isolation and characterization of urokinase from human plasma.
    Wun TC; Schleuning WD; Reich E
    J Biol Chem; 1982 Mar; 257(6):3276-83. PubMed ID: 7037781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proenzyme form of human urokinase.
    Wun TC; Ossowski L; Reich E
    J Biol Chem; 1982 Jun; 257(12):7262-8. PubMed ID: 6806270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
    Booyse FM; Osikowicz G; Feder S; Scheinbuks J
    J Biol Chem; 1984 Jun; 259(11):7198-205. PubMed ID: 6539333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
    Moroi M; Aoki N
    J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.
    Tissot JD; Schneider P; Hauert J; Ruegg M; Kruithof EK; Bachmann F
    J Clin Invest; 1982 Dec; 70(6):1320-3. PubMed ID: 6757269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proenzyme from chicken plasma similar to human plasma prekallikrein.
    Schleuning WD; Sudol M; Reich E
    J Biol Chem; 1983 Dec; 258(23):14106-15. PubMed ID: 6557113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
    Wun TC; Reich E
    J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functionally active heavy chain derived from human high molecular weight urokinase.
    Sumi H; Robbins KC
    J Biol Chem; 1983 Jul; 258(13):8014-9. PubMed ID: 6345538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
    Sudol M; Reich E
    Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fish plasminogen activators: their identification and characterization.
    Takahashi K; Wakamatsu Y; Ozato K; Wakayama Y
    Cell Struct Funct; 1987 Feb; 12(1):11-22. PubMed ID: 3552260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Jan; 261(3):1274-8. PubMed ID: 3080423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of human plasma kallikrein and urokinase by affinity chromatography.
    Tamura Y; Fujii S
    J Biochem; 1976 Sep; 80(3):507-11. PubMed ID: 824284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
    Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
    Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.
    Booyse FM; Lin PH; Traylor M; Bruce R
    J Biol Chem; 1988 Oct; 263(29):15139-45. PubMed ID: 3170576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct pathways of the streptokinase-mediated activation of highly purified human plasminogen.
    McClintock DK; Englert ME; Dziobkowski C; Snedeker EH; Bell PH
    Biochemistry; 1974 Dec; 13(26):5334-44. PubMed ID: 4279693
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D; Lijnen HR; Piérard L; de Foresta F; Demarsin E; Jacobs P; De Wilde M; Bollen A; Collen D
    J Biol Chem; 1987 Aug; 262(24):11779-84. PubMed ID: 3114253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.
    Stump DC; Thienpont M; Collen D
    J Biol Chem; 1986 Sep; 261(27):12759-66. PubMed ID: 3091604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Dec; 261(36):17120-6. PubMed ID: 3097021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
    Robbins KC; Tanaka Y
    Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.